CompaniesByCap
TGTX
TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare

TG Therapeutics, Inc. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2012Dec 2011
Operating Activities
Operating Cash Flow-24.8M-40.5M-31.4M-176.2M-295.6M-214.5M-132.8M-128.9M-93.8M-5.2M-86,577
Depreciation & Amort.59,00068,000211,000303,000282,000
Investing Activities
Capital Expenditure214,00045,000014,000401,000357,000131,00090,0002,0001,3990
Free Cash Flow-25.0M-40.6M-31.4M-176.2M-296.0M-214.9M-132.9M-129.0M-93.8M-5.2M-86,577
Financing Activities
Dividends Paid
Stock Buybacks84,538

TG Therapeutics, Inc. Cash Flow — FAQ

TG Therapeutics, Inc. (TGTX) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TGTX's cash flow history?

The chart and table above show TG Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.